These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32067864)
1. Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry. Medrek S; Sahay S; Zhao C; Selej M; Frost A J Heart Lung Transplant; 2020 Apr; 39(4):321-330. PubMed ID: 32067864 [TBL] [Abstract][Full Text] [Related]
2. Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry. Bernardo RJ; Lu D; Ramirez RL; Hedlin H; Kawut SM; Bull T; De Marco T; Ford HJ; Grinnan D; Klinger JR; McConnell JW; Berman-Rosenzweig E; Shlobin OA; Zamanian RT; de Jesus Perez VA Ann Am Thorac Soc; 2022 Sep; 19(9):1459-1468. PubMed ID: 35239467 [No Abstract] [Full Text] [Related]
3. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry. Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551 [TBL] [Abstract][Full Text] [Related]
4. Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry. Fling C; De Marco T; Kime NA; Lammi MR; Oppegard LJ; Ryan JJ; Ventetuolo CE; White RJ; Zamanian RT; Leary PJ Ann Am Thorac Soc; 2023 Dec; 20(12):1718-1725. PubMed ID: 37683277 [No Abstract] [Full Text] [Related]
5. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR). DesJardin JT; Kime N; Kolaitis NA; Kronmal RA; Lammi MR; Mathai SC; Ventetuolo CE; De Marco T; J Heart Lung Transplant; 2024 Jun; 43(6):901-910. PubMed ID: 38360160 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797 [TBL] [Abstract][Full Text] [Related]
8. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012 [TBL] [Abstract][Full Text] [Related]
9. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry. Burger CD; Long PK; Shah MR; McGoon MD; Miller DP; Romero AJ; Benton WW; Safford RE Chest; 2014 Nov; 146(5):1263-1273. PubMed ID: 24901386 [TBL] [Abstract][Full Text] [Related]
10. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis. Benza RL; Miller DP; Foreman AJ; Frost AE; Badesch DB; Benton WW; McGoon MD J Heart Lung Transplant; 2015 Mar; 34(3):356-61. PubMed ID: 25447572 [TBL] [Abstract][Full Text] [Related]
12. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257 [TBL] [Abstract][Full Text] [Related]
13. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry. Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK; Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677 [TBL] [Abstract][Full Text] [Related]
14. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881 [TBL] [Abstract][Full Text] [Related]
15. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry. Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998 [TBL] [Abstract][Full Text] [Related]
16. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. Chang KY; Duval S; Badesch DB; Bull TM; Chakinala MM; De Marco T; Frantz RP; Hemnes A; Mathai SC; Rosenzweig EB; Ryan JJ; Thenappan T; J Am Heart Assoc; 2022 May; 11(9):e024969. PubMed ID: 35475351 [TBL] [Abstract][Full Text] [Related]